Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID05327062

CRT-DRIVE: Cardiac Resynchronization Therapy Delivery Guided by Non-Invasive Electrical and Venous Anatomy Assessment

Led by XSpline S.p.A. · Updated on 2024-10-24

150

Participants Needed

13

Research Sites

26 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating a method to improve Cardiac Resynchronization Therapy (CRT) implantation by using a cloud-based pre-procedural roadmap. This roadmap integrates 3D images from electrical activation sequences and coronary venous anatomy obtained by non-invasive tests. The study aims to see if this approach can guide the placement of the left ventricular lead to areas of delayed electrical activation and reduce the heart's left ventricular end-systolic volume by at least 15% in 75% of patients six months after treatment. Participants will undergo CRT implantation guided by XSpline technology, which uses patient data including ECG, echocardiography, and computed tomography angiography. The imaging data are processed on a cloud platform to identify the best site for lead placement. The procedure follows local protocols with visual verification by X-ray to confirm lead position. The study includes at least 150 patients and compares the new approach's outcomes to previous CRT populations. During the study, participants will have their clinical and cardiovascular history recorded along with routine examinations and imaging tests. Researchers will monitor heart function changes, procedural time, and total X-ray exposure over six months. The main outcome measured is the reduction in left ventricular end-systolic volume. Safety and feasibility of the XSpline platform use for CRT implantation will also be assessed.

CONDITIONS

Brief Title

Cardiac Resynchronization Therapy Delivery Guided Non-Invasive Electrical and Venous Anatomy Assessment

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Signed and dated informed consent
  • Age 18 years or older at time of consent
  • Indication for CRT according to 2021 ESC or 2017 AHA/ACC/HFSA guidelines with class I or IIA indication and left bundle branch block
  • Sinus rhythm
  • QRS duration of 130 ms or more
  • Left ventricular ejection fraction 35% or less
  • Symptomatic heart failure NYHA class II or higher
  • Stable medical treatment for at least 6 months
  • No cardiovascular intervention within the last 6 months
Not Eligible

You will not qualify if you...

  • History of persistent or permanent atrial fibrillation
  • Previous pacemaker or ICD implantation
  • Indication for pacing due to bradycardia
  • Planned His bundle pacing or cardiac conduction pacing
  • Unstable angina
  • Recent myocardial infarction within 40 days prior to enrollment
  • Coronary artery bypass graft or valve surgery within 90 days prior to enrollment
  • Post heart transplantation or listed for transplantation or likely to undergo transplantation within next year
  • Implanted left ventricular assist device
  • On continuous inotropic therapy for heart failure
  • Severe aortic stenosis (valve area less than 1.0 cm2) or significant valve disease expected to be operated during study
  • Congenital heart disease
  • Mechanical right-sided heart valve
  • Life expectancy less than one year per investigator
  • Pregnant or breastfeeding women or women of childbearing potential not using reliable birth control
  • Enrolled in other concurrent studies that may affect results
  • Contraindications to CT scanning
  • Chronic kidney disease with estimated glomerular filtration rate less than 40 ml/min/1.73m2

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Implementation

Duration - Day of device implantation

Participants undergo CRT device implantation guided by a non-invasive electrical and venous anatomy assessment using the XSpline platform. This includes routine clinical workup, imaging, data processing, and lead placement according to local protocols.

1 visit (in-person)

Long-term Monitoring

Duration - 6 months

Participants are monitored for outcomes including reduction of left ventricular end-systolic volume and procedural parameters at 6 months after CRT implantation.

Follow-up visits over 6 months as per clinical protocol

Trial Site Locations

Total: 13 locations

1

Rush University Medical center

Chicago, Illinois, United States, 60637

Not Yet Recruiting

2

The University of Chicago Medicine

Chicago, Illinois, United States, 60637

Not Yet Recruiting

3

Massachusetts General Hospital

Boston, Massachusetts, United States, 02114

Actively Recruiting

4

Duke University Hospital

Durham, North Carolina, United States, 27710

Actively Recruiting

5

Ordensklinikum Linz Elisabethinen Hospital

Linz, Austria

Actively Recruiting

6

Semmelweis University

Budapest, Hungary

Not Yet Recruiting

7

Fondazione IRCCS Policlinico San Matteo

Pavia, Pavia, Italy

Not Yet Recruiting

8

University Tor Vergata

Roma, Roma, Italy

Not Yet Recruiting

9

General Hospital of Bolzano

Bolzano, Italy

Not Yet Recruiting

10

Ospedale S. Maria del Carmine di Rovereto

Rovereto, Italy

Not Yet Recruiting

11

Maastricht University Medical Center

Maastricht, Netherlands

Not Yet Recruiting

12

Univeristat de Barcelona

Barcelona, Spain

Actively Recruiting

13

Istituto Cardiocentro Ticino

Lugano, Switzerland

Actively Recruiting

Loading map...

Research Team

C

Claudia M Amatruda, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Similar Trials

A Phase I/II Clinical Trial to Evaluate the Safety and Effic...

Coronary Artery Bypass Grafting (CABG)

Actively Recruiting

4 locations

Post Marketing Surveillance for Finerenone in Adults With Ch...

Chronic Heart Failure

Actively Recruiting

1 location

Vericiguat Drug Use Two-arm Investigation in Chronic Heart F...

Chronic Heart Failure

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Reconstruction of three-dimensional biventricular activation based on the 12-lead electrocardiogram via patient-specific modelling.

Simone Pezzuto, Frits W Prinzen, Mark Potse...

https://pubmed.ncbi.nlm.nih.gov/33241411

2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).

Michele Brignole, Angelo Auricchio, Gonzalo Baron-Esquivias...

https://pubmed.ncbi.nlm.nih.gov/23801822